News
 
Pharmaceuticals Newsletter - May 21 to May 25, 2012
India Infoline News Service/19:38,May 25, 2012
Piramal Healthcare Limited announced today that Phase I clinical trial data for its investigational new drug candidate P1446A-05 will be presented at the Annual Meeting of the American Society for Clinical Oncology (ASCO) being convened in Chicago from June 1-5, 2012.
list India Infoline Weekly Newsletter - May 25, 2012
list Pfizer recalls Advil bottles from distributor centers
list Teva outlines financial estimates for 2012
list Ranbaxy hires advisers for resolving consent decree with USFDA

Calendar

May-2012
M T W T F S S
21 22 23 24 25 26 27
Economic Events
list Corporate Service Price (YoY)
list Hometrack Housing Survey (MoM)
Results
list No result today
IPO
listNo IPO today
 

Piramal Healthcare raises Rs 18bn for Vodafone stake: report

India Infoline News Service / 18:12 , Feb 06, 2012

The Ajay Piramal group company said over the weekend that it had bought an additional 5.5% stake in Vodafone's Indian arm from Essar for Rs 30bn.

Piramal Healthcare Ltd. has raised Rs. 18bn through commercial papers to partly fund its acquisition of further stake in Vodafone India, Rajesh Laddha, group CFO was quoted as saying.


The Ajay Piramal group company said over the weekend that it had bought an additional 5.5% stake in Vodafone's Indian arm from Essar for Rs 30bn. The deal takes its total stake in Vodafone India to about 11%.


Piramal Healthcare will not have cash left in its balance sheet after it bought a 5.5% stake in Vodafone's India unit, Ajay Piramal, Chairman of Piramal Healthcare told reporters today.


Vodafone will continue to hold a 64% stake in its India unit. 


The latest transaction completed the exit of the Essar group as a shareholder in Vodafone India.


In August 2010, Vodafone sold 5.5% of the 11% stake it had acquired from Essar to Piramal Healthcare for ~Rs 28.93bn.

 



Rate This Article Rate 1 Rate 2 Rate 3 Rate 4 Rate 5
Average rating : 5.0